Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001493152-26-051378·Findley Keri
Schedule 13G ownership disclosure
VITALITY BIOPHARMA
Common Stock, par value $0.001 per share · CUSIP: 92849B107
Event date: 2026-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Keri Findley
Shares: 12,347,888.00 · Class: 9.7%
- Tacora Capital, LP
Shares: 12,347,888.00 · Class: 9.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-26-051378
- Form type
- SCHEDULE 13G/A
- Filer
- Findley Keri
- CIK
- CIK 1866880
- Filed
- Nov 12, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership